It is commonly accepted that disseminated tumour cells survive cytotoxic chemotherapy because they are not proliferating. A new study now finds that, in contrast to this long-standing concept, both dormant and proliferative cancer cells can be protected from chemotherapy when they reside at the perivascular niche.
CITATION STYLE
Werner-Klein, M., & Klein, C. A. (2019). Therapy resistance beyond cellular dormancy. Nature Cell Biology, 21(2), 117–119. https://doi.org/10.1038/s41556-019-0276-7
Mendeley helps you to discover research relevant for your work.